Mylan To Disallow Wholesaler Investment Buying Ahead Of Price Increases
Executive Summary
Mylan will no longer allow wholesalers to investment buy ahead of price increases, CEO Milan Puskar said during a June 8 conference call.
You may also be interested in...
Watson To Acquire Schein: Generic Business Projected At $800 Mil. In 2001
Watson expects its generic drug business to top $800 mil. in revenues during 2001 after it completes the proposed acquisition of Schein.
Mylan Lorazepam Price Triples; Firm Cites Losses For Many Products
Mylan has increased the price of its generic version of lorazepam more than threefold. On March 3, the price for a bottle of 100 lorazepam 5 mg tablets increased from $16.95 to $64.31.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011